• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Ardent Health Appoints Robert DeMichiei to Board of Directors

    4/3/25 5:27:00 PM ET
    $AP
    $ARDT
    $HCAT
    $WAY
    Fluid Controls
    Industrials
    Hospital/Nursing Management
    Health Care
    Get the next $AP alert in real time by email

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors.

    A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements.

    Prior to joining UPMC, Mr. DeMichiei held various executive roles with the General Electric Company and PricewaterhouseCoopers. He is a graduate of the University of Pittsburgh.

    "We are pleased to welcome Rob to our board of directors," said Marty Bonick, Ardent Health president and CEO. "His deep understanding of healthcare finance and operations and extensive board experience will be instrumental in guiding Ardent's continued growth and focus on operational excellence."

    Mr. DeMichiei also serves on the boards of several organizations, including Waystar Holding Corp. (NASDAQ:WAY), Ampco-Pittsburgh Corporation (NYSE:AP), and Auto Club Enterprises/AAA, and is a strategic advisor to Health Catalyst (NASDAQ:HCAT) and Omega Healthcare Management Services. He will serve on the board's Audit & Compliance Committee and the Nominating & Corporate Governance Committee.

    "Rob's governance experience with publicly traded companies brings valuable insight and perspective," said Mark Sotir, chairman of the Ardent Health board. "His background – along with his leadership of one of the nation's preeminent academic health systems – will be a tremendous asset as we continue strengthening our board and advancing Ardent's long-term strategy."

    About Ardent Health

    Ardent Health (NYSE:ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and 280 sites of care with over 1,800 affiliated providers across six states. For more information, please visit ardenthealth.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250403944600/en/

    Investor Contact:

    Dave Styblo

    [email protected]

    (615) 296-3016

    Media Contact:

    Rebecca Kirkham

    [email protected]

    (615) 296-3635

    Get the next $AP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AP
    $ARDT
    $HCAT
    $WAY

    CompanyDatePrice TargetRatingAnalyst
    Health Catalyst Inc
    $HCAT
    6/17/2025Buy → Neutral
    BTIG Research
    Health Catalyst Inc
    $HCAT
    4/9/2025Outperform → In-line
    Evercore ISI
    Waystar Holding Corp.
    $WAY
    3/14/2025$45.00Buy
    Truist
    Waystar Holding Corp.
    $WAY
    2/11/2025$51.00Buy
    Jefferies
    Health Catalyst Inc
    $HCAT
    1/8/2025$9.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Ardent Health Inc.
    $ARDT
    12/17/2024$20.00Neutral
    Analyst
    Waystar Holding Corp.
    $WAY
    11/22/2024$40.00Outperform → Strong Buy
    Raymond James
    Ardent Health Inc.
    $ARDT
    11/6/2024$22.00 → $19.00Buy → Neutral
    BofA Securities
    More analyst ratings